a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology
Industry Biotechnology
A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with RCUS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then RCUS could also see price increases.
Ticker / NAME | Correlation To OCUL | 1D Price Change % | ||
---|---|---|---|---|
OCUL | 100% | +0.45% | ||
RCUS - OCUL | 47% Loosely correlated | -2.60% | ||
EYPT - OCUL | 44% Loosely correlated | +5.39% | ||
PLRX - OCUL | 44% Loosely correlated | +4.74% | ||
BEAM - OCUL | 41% Loosely correlated | -1.21% | ||
RXRX - OCUL | 40% Loosely correlated | -4.30% | ||
More |